AstraZeneca Enlists Owlstone Medical To Identify Asthma And COPD Biomarkers

Owlstone Medical has signed another major collaboration agreement with a big pharma company to use its breath biopsy services. The Cambridge, UK company is partnering with AstraZeneca to to identify novel breath biomarkers for asthma and COPD.